Expression of drug transporters in human kidney: impact of sex, age, and ethnicity

Biology of Sex Differences
Stancy JosephBeverly Lyn-Cook

Abstract

Differences in expression of drug transporters in human kidney contribute to changes in pharmacokinetics and toxicokinetics of a variety of drug compounds. The basal expression levels of genes involved in drug transport processes in the kidney introduces differences in bioavailability, distribution, and clearance of drugs, possibly influencing drug efficacy and adverse reactions. Sex differences in gene expression of transporters are a key cause of differences in sex-dependent pharmacokinetics, which may characterize many drugs and contribute to individual differences in drug efficacy and toxicity. Therefore, evaluating the expression of drug transporters in normal human kidneys is important to better understand differences in drug bioavailability, distribution, and clearance of drugs in humans. Other factors such as age and ethnicity may also contribute to individual differences in gene expression of drug transporters in the human kidney. Quantitative real-time PCR (QRT-PCR) was performed to determine the gene expression of 30 drug transporters in 95 age-matched normal human kidney tissues. Multiple Student's t-tests (Sidak-Bonferroni correction) and two-way ANOVA (Bonferroni correction) analyses were used to determine statist...Continue Reading

References

Jan 1, 1974·Gerontologia Clinica·M R Hall
Dec 3, 1999·Journal of Clinical Pharmacy and Therapeutics·E Tanaka
Jan 5, 2000·Journal of Biotechnology·O ThellinE Heinen
Feb 22, 2001·American Journal of Physiology. Renal Physiology·R K Dubey, E K Jackson
Feb 27, 2001·Current Opinion in Nephrology and Hypertension·S L SeligerC Stehman-Breen
Mar 20, 2001·JAMA : the Journal of the American Medical Association·I RodriguezR L Woosley
Jul 11, 2001·Journal of Women's Health & Gender-based Medicine
Dec 12, 2001·Molecular and Cellular Probes·S SelveyL R Griffiths
Oct 25, 2003·Oncogene·Suresh V AmbudkarMichael M Gottesman
Jan 30, 2004·British Journal of Clinical Pharmacology·P A RoutledgeK W Woodhouse
Jan 1, 1996·Pharmacoepidemiology and Drug Safety·L BowmanC D Black
Jan 28, 2005·Kidney International·Eric DaugasGary Hill
May 27, 2005·The New England Journal of Medicine·Grant R Wilkinson
May 18, 2006·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Annick SeithelAnna-Lena Ungell
Mar 21, 2007·Basic Research in Cardiology·Mariëlle C Hendriks-BalkAstrid E Alewijnse
May 15, 2007·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Constanze HilgendorfJohan Karlsson
Jul 20, 2007·Pflügers Archiv : European journal of physiology·Ivan SabolićGerhard Burckhardt
Aug 19, 2007·Clinica Chimica Acta; International Journal of Clinical Chemistry·Wenjing Ruan, Maode Lai
May 28, 2008·Gender Medicine·Sharon Silbiger, Joel Neugarten
Jul 11, 2008·Clinical Pharmacology and Therapeutics·S U YasudaS-M Huang
Feb 20, 2009·Clinical Pharmacology and Therapeutics·A J McLachlanD G Le Couteur
May 8, 2009·Age and Ageing·Balamurugan TangiisuranChakravarthi Rajkumar
Feb 2, 2010·Trends in Pharmacological Sciences·Tamara J NicolsonRuth R A Roberts
Feb 25, 2010·British Journal of Cancer·J CaradecS Loric
Apr 13, 2010·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Yu-Kun Jennifer ZhangCurtis D Klaassen
Apr 16, 2011·Molecular Pharmacology·Derina E SweeneySanjay K Nigam
Jul 27, 2011·Pharmacogenomics·Fabian Müller, Martin F Fromm
Jul 10, 2012·Expert Opinion on Drug Metabolism & Toxicology·Andrea TrevisanPatrizia Cristofori
Sep 6, 2012·International Journal of Molecular Sciences·María H HazelhoffAdriana M Torres
Aug 2, 2013·Biology of Sex Differences·Joshua C KwekelJames C Fuscoe
Oct 12, 2013·PloS One·Joshua C KwekelJames C Fuscoe
Jun 13, 2014·The Journal of Clinical Endocrinology and Metabolism·L Keoki WilliamsDavid E Lanfear

❮ Previous
Next ❯

Citations

May 7, 2016·International Journal of Molecular Sciences·Pu DuannPei-Hui Lin
Jul 8, 2016·Journal of Clinical Pharmacology·Amandla Atilano-RoqueMelanie S Joy
Jul 28, 2016·Expert Opinion on Drug Delivery·Abhirup MandalAshim K Mitra
Nov 30, 2016·Toxicologic Pathology·Michael Gochfeld
Apr 8, 2018·Nature Reviews. Nephrology·Joanne Y-C SooMelissa H Little
Jul 7, 2017·American Journal of Physiology. Renal Physiology·Ravindra BodduLisa M Curtis
Sep 28, 2015·Clinical Pharmacokinetics·Miriam G MooijSaskia N de Wildt
Oct 23, 2015·Clinical Journal of the American Society of Nephrology : CJASN·Sanjay K NigamVibha Bhatnagar
Aug 9, 2017·American Journal of Nephrology·Kimberly HardingSusanne B Nicholas
Jun 21, 2020·International Journal of Molecular Sciences·Victoria L Halperin Kuhns, Owen M Woodward
Feb 15, 2019·Frontiers in Pharmacology·Xuan ZengHongliang Yao
Oct 28, 2019·International Journal of Molecular Sciences·Stefan OswaldGiuliano Ciarimboli
Dec 5, 2020·International Journal of Molecular Sciences·Mohammed Ali SeloJohanna J Salomon
Mar 4, 2021·Pharmacological Reviews·Franck Mauvais-JarvisJoshua B Rubin
Apr 1, 2021·Renal Failure·Hao-Yang MaYang Du
Apr 22, 2021·Nature Reviews. Cancer·Sue HauptYgal Haupt
May 21, 2021·Advanced Drug Delivery Reviews·Christine M MadlaAbdul W Basit

❮ Previous
Next ❯

Software Mentioned

GraphPad Statmate

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.